Assembly Biosciences, Inc. (ASMB) vs Ovid Therapeutics (OVID)

Assembly Biosciences, Inc. and Ovid Therapeutics are both Biotechnology companies. Assembly Biosciences, Inc. and Ovid Therapeutics are of similar size ($487.3M and $481.7M). Ovid Therapeutics has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 23.2×. Ovid Therapeutics grew revenue faster over the last twelve months: 1,333.4% against 125.1%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −439.1%) and the higher return on invested capital (0.00% vs −35.1%). Across the 17 metrics below, Assembly Biosciences, Inc. leads on 15 and Ovid Therapeutics on 2.

Valuation

Metric ASMB OVID Biotechnology median
P/E 23.21 n/m 7.88
P/S 5.96 60.33 11.47
P/B 1.46 2.26 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.68 46.84 10.73
Earnings yield 4.31% (9.39%) (28.84%)
Free cash flow yield (8.64%) (11.59%) (23.03%)

Profitability

Metric ASMB OVID Biotechnology median
Gross margin 100.00% 100.00% 65.16%
Operating margin (11.75%) (742.97%) 0.00%
Net margin (0.06%) (439.11%) 0.00%
Free cash flow margin (51.53%) (697.30%) 0.00%
Return on equity (0.03%) (25.97%) (57.72%)
Return on assets (0.02%) (22.30%) (49.22%)
Return on invested capital 0.00% (35.11%) 0.00%

Growth

Metric ASMB OVID Biotechnology median
Revenue growth (TTM) 125.12% 1,333.39% 5.64%
EPS growth (last fiscal year) 91.78% 37.84% —
Revenue growth, 5-year CAGR 35.27% (10.48%) 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB OVID Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 13.99 12.39 4.73
Net debt to EBITDA 17.31 1.37 0.96

Dividend

Metric ASMB OVID Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ASMB OVID Biotechnology median
Market cap 481.73m 487.27m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack